1. Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients 
Pere Barba, José Luis Piñana, Francesc Fernández-Avilés, Jose Antonio Perez-Simón, Rodrigo Martino, Eva López-Guerrero, David Valcárcel, Montserrat Rovira, Silvana Novelli, Isabel Campos-Varela, Lucía López-Anglada, Xavier Vidal, Lucía López Corral, Enric Carreras, Jorge Sierra 
Biology of Blood and Marrow Transplantation 
Volume 17, Issue 11, Pages (November 2011)
DOI: /j.bbmt
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Pretransplantation hepatic underlying diseases in patients with abnormal pretransplantation liver function tests. Causes of pretransplantation hepatic disease in the 94 patients who presented at least 1 severe liver test abnormality before transplantation. Numbers in the figures represent the total number of patients and the prevalence of each category (%). Abbreviations: DILI, drug-induced liver injury; NASH, nonalcoholic steatohepatitis; AST, aspartate aminotransferase; ALT, alanine aminotransaminase; GGT, gamma glutamyl transpeptidase; AP, alkaline phosphatase.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Impact of pretransplantation hepatic dysfunction on transplantation outcomes. Impact of the HCT-CI criteria for severe hepatic disease on NRM (A) and OS (B). Dashed lines indicate severe abnormalities of liver function tests; continuous lines indicate normal or mild liver function tests, according to the original definition of the HCT-CI.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions